“A Canadian journal has issued corrections on 138 case reports it published over the last 25 years to add a disclaimer: The cases described are fictional … The corrections come following a January ...
Pembrolizumab-induced myocarditis: A systematic review of case reports. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.